Nanotchnology in Oncology
$ 45.5
Description
Nanotechnology in Oncology: Poorly Water-Soluble Anticancer Drugs of Bone and Bladder Cancer presents a cutting-edge exploration of how nanoscale science is transforming the treatment landscape for two challenging malignancies. Many anticancer agents used against bone and bladder tumors suffer from poor water solubility, limited bioavailability, and suboptimal therapeutic effectiveness. This book examines how nanotechnology offers innovative solutions—enhancing drug delivery, improving targeting precision, and reducing systemic toxicity. Bridging fundamental concepts with emerging clinical applications, the text provides an in-depth look at nanocarriers, nanoformulations, controlled-release systems, and surface-engineered nanoparticles designed to overcome solubility and delivery barriers. It also highlights recent research breakthroughs, comparative therapeutic outcomes, and the future potential of nanomedicine in personalized oncology. Ideal for researchers, clinicians, pharmaceutical scientists, and graduate students, this book serves as a comprehensive resource for understanding how nanotechnology is reshaping cancer therapy. It illuminates a rapidly evolving field with the promise to redefine treatment strategies for bone and bladder cancer offering hope for more effective, targeted, and patient-centered interventions. Beyond its scientific and clinical insights, this book also addresses the practical challenges of translating nanotechnology based formulations from research to real-world oncology settings. It discusses regulatory pathways, manufacturing considerations, toxicity assessment, and the hurdles that must be overcome for successful commercialization. By integrating scientific innovation with translational perspectives, this work equips readers with a holistic understanding of how next-generation nanotechnologies can become viable therapeutic tools for improving outcomes in bone and bladder cancer. An essential resource for advancing research, improving patient care, and driving the next wave of oncology breakthroughs.